Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!


Charlotte’s Web Reports Q2 2021 Results

Return of retail activity supports 11.4% YoY growth with market share gains

Charlotte's Web Reports Q2 2021 ResultsDENVER, Aug. 12, 2021 /CNW/ – (TSX: CWEB) (OTCQX: CWBHF), Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”) the market share leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2021.

Related: Full Spectrum Hemp Extract Chemistry Studies Underway at Colorado State University

All amounts are expressed in United States’ dollars, unless otherwise noted. Certain metrics, including those expressed on an adjusted basis, are non-IFRS measures.

 

Q2-2021 Financial Highlights   

  • Revenue increased 11.4% to $24.2 million vs. $21.7 million in Q2-2020
  • DTC eCommerce revenue increased 1.0% to $15.7M, contributing 64.9% of Q2 revenue and holding onto the pandemic online shopping boost
  • B2B revenue increased 37.7% year-over-year
  • Gross profit increased to $15.8 million, or 65.5% of consolidated revenue
  • Operating expense reduced by 15.2% year-over-year
  • Adjusted EBITDA of ($3.9 million), an improvement vs prior year ($5.7 million) and prior quarter ($4.7 million)
  • $27.1 million cash (plus $10.9 million pending IRS tax receivable) and $90.1 million working capital at June 30, 2021
  • $10 million unused line of credit with JPMorgan; opportunity to extend to $20 million

Business Highlights

  • Grew #1 market share across core retail channels including total US Food/Drug/Mass retail (“F/D/M”) and US natural specialty retail
  • Secured future optionality to enter the US cannabis wellness category through a purchase option agreement to acquire Stanley Brothers cannabis business pending US federal legalization of cannabis
  • Planted first crop of (proprietary) patented hemp cultivars approved by Health Canada in the Okanagan Valley in British Columbia, Canada
  • CW Labs announced a scientific collaboration, researching hemp CBD efficacy with Harvard Medical School’s Dr. Staci Gruber, Ph.D.
  • Invested $1.6 million capex primarily related to substantially completing phase III expansion of new 137,000 sq. ft. facility with extraction infrastructure and R&D expansion
  • Supported federal and state legislative actions to help develop a comprehensive regulatory framework with Federal Bill H.R. 841 and proposed regulations in CA and NY
  • Wes Booysen appointed as Chief Financial Officer, bringing international operating, finance and regulatory experience as former Molson Coors executive
  • Tim Saunders, former CFO of Canopy Growth appointed to board of directors, adding Canadian cannabis and hemp sector governance and finance expertise

“The ongoing economic recovery from the pandemic that began in Q1 strengthened through the second quarter, driving a 38% increase in our retail revenue as many consumers transitioned from online shopping back to brick and mortar retail. This was especially evident within our largest and most established medical and healthcare practitioner channels,” said Deanie Elsner, CEO of Charlotte’s Web. “We believe we are best positioned to take advantage of the return to brick and mortar retail as we hold the number one share position in the food/drug/mass and natural specialty retail channels in the US.  Internationally, we recently planted our first hemp crop in Canada and anticipate initial product sales by early 2022.”

Related: Charlotte’s Web Holdings: Will this Hemp Stock Stage a Rebound in 2020?

Q2-2021 Financial Review
The following table sets forth selected financial information for the periods indicated.

Three months ended June 30,

U.S. $ millions, except per share data

2021

2020

Revenue

$

24.2

$

21.7

Gross profit before biological assets adjustment

15.8

11.5

Net impact, fair value of biological assets

Gross profit

15.8

11.5

Operating expenses

25.0

29.5

Operating loss

(9.2)

(18.0)

Change in fair value of financial instruments, net

(4.1)

(3.9)

Net loss and comprehensive loss

(5.4)

(14.4)

Loss per share – basic

$

(0.04)

$

(0.13)

Loss per share – diluted

$

(0.04)

$

(0.13)

Adjusted EBITDA¹

$

(3.9)

$

(5.7)

Assets:

June 30, 2021

December 31, 2020

Cash and cash equivalents

$

27.1

$

52.8

Total assets

$

285.9

$

310.9

Liabilities:

Long-term liabilities

$

22.6

$

27.7

Total liabilities

$

46.8

$

56.7

The following information sets forth selected quarterly revenue information for the Company’s recent fiscal quarters.

U.S. $ millions

Q2

Q1

Q4

Q3

Q2

Q1

Q4

Q3

2021

2021

2020

2020

2020

2020

2019

2019

Revenue

$

24.2

$

23.4

$

26.9

$

25.2

$

21.7

$

21.5

$

22.8

$

25.0

Consolidated revenue for the three months ended June 30, 2021 increased 11.4% year-over-year to $24.2 million.

Consolidated business-to-business (“B2B”) revenue increased 37.7% year-over-year reflecting consumers returning to brick & mortar retail shopping following the economic reopening from pandemic lockdowns. Similarly, B2B healthcare practitioner (“HCP”) and medical channels experienced increased activity and revenue, additionally supported by the Company’s acquisition of Abacus Health in June 2020.

Direct-to-consumer (“DTC”)  ecommerce net sales grew by 1.0% year-over-year, reflecting some consumer transition back to retail shopping. Year-over-year new subscriptions increased 43% and conversion rates increased 27%. DTC accounted for  64.9% of total revenue in the second quarter of 2021 versus 71.6% for the same period in 2020.

Increased retail volumes have resulted in ongoing incremental quarterly gains in retail market share. Charlotte’s Web grew its number one market share across its core retail channels, including total US Food/Drug/Mass retail, total US natural specialty retail.

Three months ended

Year-over-year

June 30,

% Increase

2021

2020

Revenue – U.S. $ millions

$

24.2

$

21.7

11.4%

Direct-to-consumer (“DTC”)

$

15.7

$

15.5

1.0%

Business-to-business (“B2B”)

$

8.5

$

6.2

37.7%

Gross profit of $15.8 million strengthened to 65.5% of revenue compared to $11.5 million, or 52.9% of revenue in Q2-2020, which included inventory provisions of $2.5 million taken in the quarter for expiring product (gross profit before inventory provisions was 64.6%).   The Company anticipates gross profit improvements as its new production and fulfillment facility becomes fully operational.

Operating expenses were $25.0 million, a 15.2% year-over-year improvement from $29.5 million. In response to lower B2B retail sales during the pandemic, in Q4-2020 management took actions to better align operating expenses through an expense optimization program targeting reductions of more than 10% of the Q3-2020 consolidated expense run rate. Operating expenses reductions for the first half of 2021 were ahead of plan and were achieved despite incurring the additional operating expenses from the CW Labs R&D division as well as the acquisition of Abacus Health, which were not present for the full first six months of 2020.

Adjusted EBITDA for the quarter was negative $3.9 million, or (16.3)% of consolidated revenue, a 31.1% improvement from negative Adjusted EBITDA of $5.7 million, or (26.6)% of consolidated revenue, for the second quarter of 2020.

Balance Sheet and Cash Flow
The Company used $6.5 million of cash in operations during the second quarter of 2021 compared to $7.1 million of cash used in operations during the second quarter of 2020. The Company’s cash and working capital at June 30, 2021 were $27.1 million and $90.1 million, respectively, compared to $52.8 million and $113.6 million at December 31, 2020. Charlotte’s Web has a near-term IRS tax receivable of $10.9 million and maintains a unused $10 million line of credit with JPMorgan, with opportunity to extend to $20 million.

Three months ended

June 30

U.S. $ millions

2021

2020

$ Change

% Change

Cash beginning of period

$

35.0

$

53.0

$

(18.0)

(34.0)%

Cash flows from (used in):

Operating activities

(6.5)

(7.1)

0.6

(8.5)%

Investing activities

(1.3)

0.8

(2.1)

(262.5)%

Financing activities

(0.1)

53.1

(53.2)

(100.2)%

Cash, end of period

$

27.1

$

99.8

$

(72.7)

(72.8)%

Charlotte’s Web Reports Q2 2021 Results

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s unaudited financial statements and accompanying notes for the periods ended June 30, 2021 and 2020 and related management’s discussion and analysis of financial condition and results of operations (“MD&A”) are available under the Company’s profile on SEDAR at www.sedar.com and on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

Conference Call
Management will host a conference call to discuss the Company’s second quarter 2021 results at 8:30a.m. ET on August 12, 2021. To participate in the call, please dial 1-416-764-8659 or 1-888-664-6392 approximately 10 minutes before the conference call. A recording of the call will be available through August 19, 2021. To listen to the rebroadcast please dial 1-416-764-8677 and provide   conference ID 506847. A webcast of the call can be accessed through the investor relations section of the Charlotte’s Web website.

Charlotte’s Web Reports Q2 2021 Results

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Denver, Colorado, is the market leader in innovative hemp extract wellness products under a family of brands which includes Charlotte’s Web™, CBD Medic™, CBD Clinic™, and Harmony Hemp™. Charlotte’s Web branded premium quality products start with proprietary hemp genetics that are 100-percent American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids including cannabidiol (“CBD”), CBC, CBG, terpenes, flavonoids and other beneficial hemp compounds. The Company’s CW Labs R&D science division is located at the University at Buffalo in New York which is part of the State University of New York (SUNY) system of 64 universities. Charlotte’s Web product categories include full spectrum hemp extract oil  tinctures (liquid products), gummies (sleep, stress, inflammation recovery), capsules, CBD topical creams and lotions, as well as products for dogs. Charlotte’s Web products are distributed to more than 14,000 retail doors and  8,000 health care practitioners, and online through the Company’s website at www.CharlottesWeb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF” As of August 10, 2021, Charlotte’s Web had 123,165,213 Common Shares outstanding and 42,931.5675 Proportionate Voting Shares convertible at 400:1 into Common Shares, for an effective equivalent of 140,337,840 Common Shares outstanding.

Charlotte’s Web Reports Q2 2021 Results

Non-IFRS Measures
Adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) is not a recognized performance measure under International Financial Reporting Standards (“IFRS”). Adjusted EBITDA does not have a standardized meaning prescribed by IFRS and therefore may not be comparable to ‎similar measures presented by other issuers. ‎ The term EBITDA consists of net loss and excludes interest (“financing costs”), taxes, depreciation and amortization. Adjusted EBITDA also excludes share-based compensation, impairment of assets, transaction costs, legal settlement costs, restructuring charges, and adjustments for fair value. Adjusted EBITDA is included as a supplemental disclosure because Management believes that such measurement provides a more meaningful assessment of the Company’s operations on a continuing basis by eliminating certain non-cash charges and charges or gains that are infrequent. The most directly comparable measure to Adjusted EBITDA calculated in accordance with IFRS is net loss. See “Adjusted EBITDA” in the MD&A for a reconciliation of Adjusted EBITDA to net loss. 

 

Three months ended

June 30,

U.S. $ millions

2021

2020

Net loss and comprehensive loss

$

(5.4)

$

(14.4)

Depreciation of property and equipment and amortization of intangibles

3.6

2.1

Financing costs

0.3

0.3

Interest income

Income tax benefit

EBITDA

$

(1.5)

$

(12.0)

Mark-to-market financial instruments

(4.0)

(3.9)

Net impact, fair value of biological assets

Share-based compensation

1.5

2.0

Impairment of assets

(0.2)

2.5

Transaction costs

3.1

Legal settlement

2.1

Restructuring charges

0.3

0.5

Adjusted EBITDA

$

(3.9)

$

(5.7)

Forward-Looking Information
 
In the interest of providing the shareholders and potential investors of Charlotte’s Web Holdings, Inc. with information about the Company,  certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”). Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Although these forward-looking statements are based on assumptions the Company considers to be reasonable based on the information available on the date such statements are made, such statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company (“Management”) in light of its experience and perception of historical trends, current conditions and expected future development and other factors that it believes are appropriate.

Specifically, this press release contains forward-looking statements relating to, but not limited to: future optionality to enter the US cannabis wellness category; pending US federal legalization of cannabis; potential capacity expansion for production, extraction, R&D and distribution; international expansion activities and strategy; timing of initial product sales in Canada; capacity expansion and transition to a CPG operating company capable of supporting mass retail channel growth; future availability of line of credit and expansion of same; the impact of certain activities on the Company’s business and financial condition; suggested regulatory developments; possible equity and debt financing; the Company’s anticipated trajectory, long-term growth expectations and shareholder value creation; and product expansion, including into cannabis wellness where federally permissible.

Charlotte’s Web Reports Q2 2021 Results

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to, the following: (i) the impact of the COVID-19 pandemic; (ii) the regulatory climate in which the Company currently operates and may in the future operate; (iii) the continued sales success of the Company’s products; (iv) the continued success of sales and marketing activities; (v) the Company’s ability to complete the conversion or buildout of its facilities on time and on budget; (vi) there will be no significant delays in the development and commercialization of the Company’s products; (vii) the Company will continue to maintain sufficient and effective production and research and development capabilities to compete on the attributes and cost of its products; (viii) the Company’s ability to deal with adverse growing conditions (due to pests, disease, fungus, climate or other factors) in a timely and cost-effective manner; (ix) there will be no significant reduction in the availability of qualified and cost-effective human resources; * new products will continue to be added to the Company’s portfolio; (xi) demand for the Company’s  products will grow in the foreseeable future; (xii) there will be no significant barriers to the acceptance of the Company’s products in the market; (xiii) the Company will be able to maintain compliance with applicable contractual and regulatory obligations and requirements; (xiv) there will be adequate liquidity available to the Company to carry out its operations; (xv) products do not develop that would render the Company’s current and future product offerings undesirable and the Company is otherwise able to minimize the impact of competition and keep pace with changing consumer preferences; and (xvi) the Company will be able to successfully manage and integrate acquisitions and take advantage of synergies from acquisitions.

Charlotte’s Web Reports Q2 2021 Results

The Company’s forward-looking statements are subject to risks and uncertainties pertaining to, among other things, the adverse impact of the COVID-19 pandemic to the Company’s operations, supply chain, distribution chain, and to the broader market for the Company’s products, revenue fluctuations, nature of government regulations (both domestic and foreign), economic conditions, loss of key customers, retention and availability of executive talent, competing products, common share price volatility, loss of proprietary information, product acceptance, internet and system infrastructure functionality, information technology security, cash available to fund operations, crop risk, availability of capital, international and political considerations, the successful integration of acquired businesses, regulatory changes, and including but not limited to those risks and uncertainties discussed under the heading “Risks and Uncertainties” in MD&A, the Company’s most recently filed annual information form, and the Company’s other filings with securities regulators available on SEDAR. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company’s future course of action depends on Management’s assessment of all information available at the relevant time. Except to the extent required by law, the Company assumes no obligation to publicly update or revise any forward-looking statements made, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

Charlotte’s Web Reports Q2 2021 Results

CHARLOTTE’S WEB HOLDINGS, INC.

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(In thousands of United States dollars)

June 30, 2021

December 31, 2020

ASSETS

Current assets:

Cash and cash equivalents

$

27,096

$

52,803

Trade and other receivables, net

4,635

6,274

Note receivable

1,416

1,753

Note receivable – related party

1,020

1,004

Inventories

62,245

61,936

Prepaid expenses and other current assets

7,024

7,390

Income taxes receivable

10,897

11,440

114,333

142,600

Non-current assets:

Property and equipment, net

60,343

60,269

Intangible assets, net

24,011

25,376

Goodwill

77,454

77,454

SBH Purchase Option

7,170

Deferred tax assets

4

4

Other long-term assets

2,569

5,178

$

285,884

$

310,881

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$

6,024

$

4,891

Accrued liabilities

8,773

11,519

Deferred revenue

568

615

Current cultivation liabilities

6,608

9,304

Current notes payable

312

629

Current lease obligations

1,903

2,015

24,188

28,973

Non-current liabilities:

Long-term cultivation liabilities

2,513

Long-term notes payable

144

Long-term lease obligations

19,623

20,567

Warrant liabilities

2,861

4,304

Other long-term liabilities

136

151

46,808

56,652

Shareholders’ equity:

Share capital

281,437

279,308

Contributed surplus

21,881

19,849

Accumulated deficit

(64,242)

(44,928)

239,076

254,229

$

285,884

$

310,881

 

CHARLOTTE’S WEB HOLDINGS, INC.

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS AND OTHER COMPREHENSIVE LOSS

(In thousands of United States dollars, except per share amounts)

Three months ended June 30,

2021

2020

Revenue

$

24,152

$

21,680

Cost of sales

8,325

10,209

Gross profit before (gain) loss on fair value of biological assets

15,827

11,471

Realized fair value (gain) included in inventory sold

(4)

Unrealized fair value loss on growth of biological assets

Gross profit

15,827

11,475

Expenses:

General and administrative

14,885

21,108

Sales and marketing

8,454

6,835

Research and development

1,655

1,533

Operating expenses

24,994

29,476

Operating loss

(9,167)

(18,001)

Financing costs

324

364

Interest income

(16)

(26)

Change in fair value of financial instruments, net

(4,087)

(3,929)

Loss before taxes

(5,388)

(14,410)

Income tax expense

20

Net loss and comprehensive loss

$

(5,388)

$

(14,430)

Weighted average number of common shares – basic

139,936,443

114,206,250

Weighted average number of common shares – diluted

139,936,443

114,206,250

Loss per share – basic

$

(0.04)

$

(0.13)

Loss per share – diluted

$

(0.04)

$

(0.13)

 

 

CHARLOTTE’S WEB HOLDINGS, INC.

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands of United States dollars)

Six months ended June 30, 2020

Share capital

Contributed

surplus

Accumulated
deficit

Total

Balance – December 31, 2019

$

123,927

$

27,513

$

2,258

$

153,698

Exercise of common stock options

2,006

(558)

1,448

Accumulated effect of income tax from stock options

(16,087)

(16,087)

Share-based compensation expense

2,310

2,310

2020 Share Offering

47,959

47,959

Share issuance costs

(3,368)

(3,368)

Abacus acquisition

105,461

5,407

110,868

Net loss and comprehensive loss

(25,929)

(25,929)

Balance – June 30, 2020

$

275,985

$

18,585

$

(23,671)

$

270,899

Six months ended June 30, 2021

Share capital

Contributed
surplus

Accumulated
deficit

Total

Balance – December 31, 2020

$

279,308

$

19,849

$

(44,928)

$

254,229

Exercise of common stock options

61

(31)

30

Exercise of common stock warrants

485

(45)

440

Withholding of common stock upon vesting of restricted share awards

744

(882)

(138)

Accumulated effect of income tax from stock options

Share-based compensation expense

2,990

2,990

ATM Program

1,282

1,282

Share issuance costs

(443)

(443)

Net loss and comprehensive loss

(19,314)

(19,314)

Balance – June 30, 2021

$

281,437

$

21,881

$

(64,242)

$

239,076

 

 

CHARLOTTE’S WEB HOLDINGS, INC.

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of United States dollars)

Six months ended June 30,

2021

2020

Cash flows from operating activities:

Net loss

$

(19,314)

$

(25,929)

Items not involving cash:

Depreciation

5,202

3,486

Amortization

1,770

445

Change in fair value of biological assets

(41)

(86)

Change in fair value of warrant liabilities

(1,443)

(6,705)

Change in fair value of SBH Purchase Option

830

Expected credit losses

515

(9)

Inventory provision, net

178

2,523

Share-based compensation

2,990

2,310

Loss on disposal of assets

93

7

Deferred income taxes

14,330

Changes in working capital:

Trade and other receivables, net

1,124

(3,095)

Inventories

(315)

584

Prepaid expenses and other current assets

66

(2,739)

Accounts payable

1,133

2,058

Accrued liabilities

(2,911)

2,288

Income taxes

543

(8,034)

Cultivation liabilities

(5,243)

(3,596)

Other operating assets and liabilities, net

549

184

(14,274)

(21,978)

Cash flows from investing activities:

Cash acquired in business combinations

11,181

Purchases of property and equipment

(2,927)

(8,930)

Purchases of intangible assets

(341)

(1,257)

Proceeds from sale of assets

9

41

Funding of notes receivable

(936)

Collections on note receivable

363

Investment in SBH Purchase Option

(8,000)

Other investing activities

507

(895)

(10,389)

(796)

Cash flows from financing activities:

Proceeds from public offering

1,282

57,165

Proceeds from common stock option exercises

30

1,448

Proceeds from common stock warrant exercises

440

Withholding of common stock upon vesting of restricted share awards

(138)

Payments on notes payable

(461)

(5)

Payments on lease obligations

(1,893)

(1,199)

Share issuance costs

(304)

(3,368)

(1,044)

54,041

(Decrease) increase in cash

(25,707)

31,267

Cash and cash equivalents, beginning of year

52,803

68,553

Cash and cash equivalents, end of period

$

27,096

$

99,820

Supplemental disclosures of cash flows from operating activities:

Cash paid for interest

$

(53)

$

(48)

Cash paid for interest on lease obligations

(619)

(486)

Cash received from interest

35

155

Cash received (paid) for taxes

569

(42)

Non-cash purchases of property and equipment

(2,364)

(3,649)

Non-cash purchases of intangible assets

(64)

Charlotte’s Web Reports Q2 2021 Results


Cannin Investment Group: Your Hemp Stocks Experts

Cannin.com is your trusted resource for top hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2021. 

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now. 

Are you interested in the best hemp stocks for 2021 like HempFusion, Inc., Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or stock in cannabis companies in 2021? Interested in penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +30% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at cannin.com.

Charlotte’s Web Reports Q2 2021 Results